Skip to main content
Top

German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer

Published in:

Abstract

The updated edition of the German, Austrian and Swiss Guidelines for Systemic Treatment of Gastric Cancer was completed in August 2023, incorporating new evidence that emerged after publication of the previous edition. It consists of a text-based “Diagnosis” part and a “Therapy” part including recommendations and treatment algorithms. The treatment part includes a comprehensive description regarding perioperative and palliative systemic therapy for gastric cancer and summarizes recommended standard of care for surgery and endoscopic resection. The guidelines are based on a literature search and evaluation by a multidisciplinary panel of experts nominated by the hematology and oncology scientific societies of the three involved countries.
Title
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer
Authors
Florian Lordick
Salah-Eddin Al-Batran
Dirk Arnold
Markus Borner
Christiane J. Bruns
Wolfgang Eisterer
Gerhard Faber
Ines Gockel
Dieter Köberle
Sylvie Lorenzen
Markus Möhler
Ron Pritzkuleit
Michael Stahl
Peter Thuss-Patience
Ewald Wöll
Thomas Zander
Georg Maschmeyer
For the Germany Society of Hematology and Medical Oncology (DGHO, Austrian Society of Hematology and Oncology (OeGHO), Swiss Society of Hematology (SSH), Swiss Society of Medical Oncology (SGMO); in collaboration with the Arbeitsgemeinschaft Internistische Onkologie (AIO) of the German Cancer Society
Publication date
17-10-2023
Publisher
Springer Nature Singapore
Published in
Gastric Cancer / Issue 1/2024
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-023-01424-y
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on progress in colorectal cancer

  • Live
  • Webinar | 11-12-2025 | 18:00 (CET)

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Watch it live: Thursday 11 December 2025, 18:00-19:30 (CET)

Prof. Antoni Castells
Prof. Edward Giovannucci
Prof. Harpreet Wasan
Join the webinar
Webinar

Are you up to date on targeted therapies for relapsed/refractory AML? 

Join Prof. Amer Zeidan and his expert guests to hear about innovations in molecular testing, emerging therapies, and IDH-targeted treatments, and get practical advice for improving your patient care.

Supported by: independent educational grant from Rigel

Find out more
Image Credits
File folder labelled as guidelines/© tashatuvango / Fotolia, Colon cancer illustration/© (M) KATERYNA KON / SCIENCE PHOTO LIBRARY / Getty Images